(Q47978606)

English

Allogeneic Dendritic Cells Fused with Tumor Cells: Preclinical Results and Outcome of a Clinical Phase I/II Trial in Patients with Metastatic Renal Cell Carcinoma

scientific article published on March 20, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/12691613

Allogeneic Dendritic Cells Fused with Tumor Cells: Preclinical Results and Outcome of a Clinical Phase I/II Trial in Patients with Metastatic Renal Cell Carcinoma (English)

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

phase II clinical trial

0 references

phase I clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

molecular medicine

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

author name string

Angela Märten

1

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/12691613

Sabine Renoth

2

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/12691613

Thomas Heinicke

3

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/12691613

Peter Albers

4

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/12691613

Andreas Pauli

5

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/12691613

Ulrich Mey

6

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/12691613

Reiner Caspari

7

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/12691613

Dimitri Flieger

8

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/12691613

Peter Hanfland

9

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/12691613

Alexander Von Ruecker

10

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/12691613

Stefan Müller

12

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/12691613

Ingo Schwaner

13

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/12691613

Uwe Lohmann

14

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/12691613

Guido Heylmann

15

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/12691613

Tilman Sauerbruch

16

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/12691613

Anna M. Eis-Hübinger

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12691613

23 December 2023

Ingo G. H. Schmidt-Wolf

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12691613

23 December 2023

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12691613

23 December 2023

publication date

1 March 2003

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/12691613

20 March 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12691613

23 December 2023

full work available at URL

http://www.liebertpub.com/doi/pdf/10.1089/104303403321467243

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

Human Gene Therapy

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/12691613

14

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/12691613

5

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/12691613

483-494

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/12691613

Dendritic cells and the control of immunity

1

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

Europium-labelled target cells in an assay of natural killer cell activity. I. A novel non-radioactive method based on time-resolved fluorescence

2

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

3

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid

4

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

5

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

Molecular expression of PSMA mRNA and protein in primary renal tumors.

6

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells

7

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity

8

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

Fusion induces tumour rejection

9

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

CD83+ blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer

10

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

A rapid and simple procedure for dissociation of tumor tissue from the human colon

11

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

12

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

Interleukin-2 based home therapy of metastatic renal cell carcinoma: risks and benefits in 215 consecutive single institution patients

13

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial

14

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

Renal-cell carcinoma

15

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

Dendritic cells as adjuvants for immune-mediated resistance to tumors

17

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity

19

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases

20

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

Recruitment of helper T cells for induction of tumour rejection by cytolytic T lymphocytes

21

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

Hybrid cell vaccination for cancer immune therapy: first clinical trial with metastatic melanoma.

22

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription

23

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

Enumeration of IFN-gamma-producing human lymphocytes by spot-ELISA. A method to detect lymphokine-producing lymphocytes at the single-cell level

24

1 reference

10.1089/104303403321467243

https://api.crossref.org/works/10.1089/104303403321467243

23 December 2023

Identifiers

10.1089/104303403321467243

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/12691613

release_un2znz2abbbivncqkknslhy7z4

1 reference

https://api.fatcat.wiki/v0/release/un2znz2abbbivncqkknslhy7z4

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/12691613

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47978606&oldid=2034940268"